Gastrointestinal Endoscopy

Fujifilm Exhibits Full Endoscopic and Endosurgical Portfolio at the American College of Gastroenterology Annual Scientific 2021 Meeting

Retrieved on: 
星期四, 十月 21, 2021
Fujifilm, Magnetic resonance imaging, Method, Endoscopy, Adenoma, Diagnosis, Technology, Knowledge, OEM, FLAT, Gastrointestinal Endoscopy, THE, Supplement, Comparison, Gastroenterology, EUS, FDA, Food, Mammography, Colonoscopy, LCI, Regulation of tobacco by the U.S. Food and Drug Administration, Fatigue, Image, NYU Langone Health, Hepatology, Laboratory, Solution, American College, BLI, GLOBE, Microcirculation, Department, ISSN, American College of Gastroenterology, ACG, Physician, Enterprise imaging, Nightclub, Medical device, Medical imaging

At the event, Fujifilm will showcase for the first time the G-EYE 700 Series Colonoscopes, now commercialized for use in the U.S.

Key Points: 
  • At the event, Fujifilm will showcase for the first time the G-EYE 700 Series Colonoscopes, now commercialized for use in the U.S.
  • This innovative technology was developed by Smart Medical Systems Ltd., and is distributed by Fujifilm.
  • G-EYE 700 Series Colonoscopes are designed to assist with visualization, stabilization and control during routine examinations.
  • The innovative design of the Fujifilm colonoscope is otherwise unchanged, and insertion can be performed as usual with the balloon deflated.

Austin L. Chiang, M.D., M.P.H. joins Medtronic as Chief Medical Officer for Gastrointestinal business

Retrieved on: 
星期四, 十月 21, 2021
American Board of Obesity Medicine, Thomas Jefferson University Hospital, Engineering, Disruption, Harvard T.H. Chan School of Public Health, Technology, LinkedIn, Risk management, Association, Thomas Jefferson University, NewYork-Presbyterian Hospital, American Society for Gastrointestinal Endoscopy, MBA, Gastrointestinal Endoscopy, Duke University, Twitter, Doctor of Medicine, Security (finance), U.S. Securities and Exchange Commission, Patient, Internal medicine, Harvard University, NYSE, Medicine, ABE, 21st GLAAD Media Awards, Social media, Hospital, Public health, CEO, ASGE, Obesity medicine, Jefferson Health, Solution, Health, American College, Columbia University, Publication, Society, American Board of Internal Medicine, CMO, American Board of Commissioners for Foreign Missions, American College of Gastroenterology, ACG, Management, Medical device

DUBLIN, Oct. 21, 2021 /PRNewswire/ --Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced Austin L. Chiang, M.D., M.P.H., assistant professor of medicine at Sidney Kimmel Medical College, chief medical social media officer of Jefferson Health and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, has joined Medtronic as Chief Medical Officer (CMO) of the Gastrointestinal (GI) business at Medtronic.

Key Points: 
  • DUBLIN, Oct. 21, 2021 /PRNewswire/ --Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced Austin L. Chiang, M.D., M.P.H., assistant professor of medicine at Sidney Kimmel Medical College, chief medical social media officer of Jefferson Health and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, has joined Medtronic as Chief Medical Officer (CMO) of the Gastrointestinal (GI) business at Medtronic.
  • His forward thinking and desire to personalize medicine for patients and providers will help Medtronic to continue evolving and serving the ever-changing healthcare community."
  • In addition to serving as Chief Medical Officer for the Medtronic GI business, Dr. Chiang will continue to practice clinically at Jefferson Health.
  • For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn .

Timothy Ritter, MD of GI Alliance Joins Iterative Scopes Scientific Advisory Board

Retrieved on: 
星期五, 十月 1, 2021
Research, Technology, Surgery, Clinical Trials, Software, Biotechnology, Pharmaceutical, Health, Science, Other Science, Bachelor of Science, Texas Society of Architects, Clinical trial, Texas A&M University, Human, IBD, MIT, Parkland Memorial Hospital, Patient, Artificial intelligence, Coronavirus Scientific Advisory Board (Turkey), Health, MD, American College, CEO, Degenerative disease, Education, University, Private sector, Inflammatory bowel disease, Leadership, American Gastroenterological Association, Founder, Research, Drug development, Hereditary nonpolyposis colorectal cancer, Gastrointestinal Endoscopy, American Society for Gastrointestinal Endoscopy, Internal medicine, American College of Gastroenterology, Society, Department, Pharmaceutical industry, Medicine

Iterative Scopes, a pioneer in the development of precision-based technologies for treating gastrointestinal diseases, announced today the appointment of Timothy Ritter, MD to its Scientific Advisory Board beginning September 2021.

Key Points: 
  • Iterative Scopes, a pioneer in the development of precision-based technologies for treating gastrointestinal diseases, announced today the appointment of Timothy Ritter, MD to its Scientific Advisory Board beginning September 2021.
  • Dr. Ritter is a board-certified gastroenterologist who is the founder and director of the Department of Clinical Research and Education at the GI Alliance, the largest physician-led GI network in the United States.
  • The GI Alliance offers comprehensive gastrointestinal care and operates more than 255 centers across 10 states, with more than 650 clinicians.
  • He has consistently shown thought leadership in the development of clinical research and has authored many posters and manuscripts on IBD.

Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus

Retrieved on: 
星期四, 九月 16, 2021
Institute of technology, Artificial intelligence, Shoulder, Barrett's esophagus, University, Associate, Technology, Teaching hospital, GI, Applied science, Patient, Colon, University of Oxford, European Society of Neurogastroenterology and Motility, Esophageal cancer, Gastrointestinal Endoscopy, University of Augsburg, Endoscopy, Extrapyramidal system, Dysplasia, Technical University of Applied Sciences Wildau, Esophagus, Google Images, Medical image computing, ESGE, OTH, Gastrointestinal disease, Research, John Radcliffe Hospital, Health, Medical device, Medical imaging

VANCOUVER, BC, Sept. 16, 2021 /PRNewswire/ -- Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany. Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable. Barrett's is a gastrointestinal condition affecting around 150 million people globally. Terms of the transaction were not disclosed.

Key Points: 
  • Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable.
  • Satisfai Health's licensing of AI-enhanced software will provide clinicians with faster, more effective diagnostics during endoscopic procedures.
  • Diagnosis entails imaging and biopsies of the esophagus to check for precancerous cells (dysplasia) which can be treated to prevent esophageal cancer.
  • Satisfai Health is a leading medical solutions provider specializing in AI applications for gastroenterology.

Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus

Retrieved on: 
星期四, 九月 16, 2021
Institute of technology, Artificial intelligence, Shoulder, Barrett's esophagus, University, Associate, Technology, Teaching hospital, GI, Applied science, Patient, Colon, University of Oxford, European Society of Neurogastroenterology and Motility, Esophageal cancer, Gastrointestinal Endoscopy, University of Augsburg, Endoscopy, Extrapyramidal system, Dysplasia, Technical University of Applied Sciences Wildau, Esophagus, Google Images, Medical image computing, ESGE, OTH, Gastrointestinal disease, Research, John Radcliffe Hospital, Health, Medical device, Medical imaging

VANCOUVER, BC, Sept. 16, 2021 /PRNewswire/ -- Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany. Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable. Barrett's is a gastrointestinal condition affecting around 150 million people globally. Terms of the transaction were not disclosed.

Key Points: 
  • Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable.
  • Satisfai Health's licensing of AI-enhanced software will provide clinicians with faster, more effective diagnostics during endoscopic procedures.
  • Diagnosis entails imaging and biopsies of the esophagus to check for precancerous cells (dysplasia) which can be treated to prevent esophageal cancer.
  • Satisfai Health is a leading medical solutions provider specializing in AI applications for gastroenterology.

NYU Langone Division of Gastroenterology & Hepatology Appoints Director of Outcomes Research

Retrieved on: 
星期一, 八月 23, 2021
Aga Khan University, Gastrointestinal Endoscopy, Research, Review, Internal medicine, Colorectal cancer, Outcomes research, Department, University, Emory University, Minneapolis, International health, National, MPH, Risk, Disease, Veterans' affairs, Hepatology, Population health, Colonoscopy, NYU, United States Department of Veterans Affairs, American College of Gastroenterology, Diagnosis, NYU Langone Health, Division, University of Minnesota Medical School, University of Minnesota, Mortality, Section, Faculty, Organization, American Society for Gastrointestinal Endoscopy, Cancer, Minnesota, Population, Society, Epidemiology, Clinical, Degenerative disease, Johns Hopkins Bloomberg School of Public Health, Patient, New York University Grossman School of Medicine, Public health, Management, Medicine, Medical imaging

NEW YORK, Aug. 23, 2021 /PRNewswire/ -- Aasma Shaukat, MD, MPH , a renowned leader in the field of gastroenterology has joined NYU Langone Health as the Director of Outcomes Research within the Division of Gastroenterology and Hepatology.

Key Points: 
  • NEW YORK, Aug. 23, 2021 /PRNewswire/ -- Aasma Shaukat, MD, MPH , a renowned leader in the field of gastroenterology has joined NYU Langone Health as the Director of Outcomes Research within the Division of Gastroenterology and Hepatology.
  • In addition to her role within the Division of Gastroenterology and Hepatology, she will serve as Co-Director of Translational Research Education and Careers, within the Clinical and Translational Science Institute , at NYU Grossman School of Medicine.Dr.
  • At NYU Langone, Dr. Shaukat will build a premier outcomes research program in all areas of gastrointestinal care, across the Division of Gastroenterology and Hepatology.
  • Her own research will include the study of colorectal cancer risk factors, screening modalities, long-term outcomes, and quality indicators for colonoscopy.

Verily Opens New R&D Center in Israel Focused on the Application of AI in Healthcare

Retrieved on: 
星期四, 八月 5, 2021
Data Management, Biotechnology, Technology, Other Health, Health, Oncology, Medical Devices, Research, Surgery, Science, Clinical Trials, Shaare Zedek Medical Center, Research, Institutional review board, Endoscopy, Ministry of Health (Saudi Arabia), Population, ICF, Gastroenterology, Diagnosis, Data science, Technology, History, Health maintenance organization, Shaare Zedek, IRB, Polyp (medicine), Patient, Software, Google Health, Artificial intelligence, Gastrointestinal Endoscopy, Polyp, Hospital, Culture, Innovation Center station, Ministry, Ecosystem, National Environmental Engineering Research Institute, Computer science, Blog, Google, Medical imaging, Medical device

The Verily Israel team will focus on applying artificial intelligence (AI) techniques to important biomedical problems, including applications in endoscopy, minimally invasive surgery and other imaging modalities.

Key Points: 
  • The Verily Israel team will focus on applying artificial intelligence (AI) techniques to important biomedical problems, including applications in endoscopy, minimally invasive surgery and other imaging modalities.
  • The objective of the validation was to determine whether the application of AI could improve the detection of colonic polyps versus human evaluation alone.
  • We are looking forward to fulfilling Verilys vision here in Israel, contributing both to Verily and to the wider Israel healthcare system.
  • Individuals interested in joining Verily should visit https://verily.com/roles/?q=Israel
    Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare.

Mercy Medical Center's Drs. Paul Thuluvath and Sergey Kantsevoy Acclaimed as Among "Top 2% of World's Scientists"

Retrieved on: 
星期二, 十二月 15, 2020
Medical specialties, Medicine, Clinical medicine, Gastroenterology, Hepatology, Gastrointestinal Endoscopy, Endoscopy, Fellows of the Royal College of Physicians, László Czakó, Hashem El-Serag

Dr. Kantsevoy is internationally recognized as a Fellow of the Japan Gastroenterological Endoscopy Society (FJGES) - a prestigious professional designation for gastroenterologists with expertise in endoscopic procedures.

Key Points: 
  • Dr. Kantsevoy is internationally recognized as a Fellow of the Japan Gastroenterological Endoscopy Society (FJGES) - a prestigious professional designation for gastroenterologists with expertise in endoscopic procedures.
  • Paul J. Thuluvath, M.D., is the Medical Director of The Institute for Digestive Health & Liver Disease at the Mercy Medical Center, and the Director of the University of Maryland Advanced Hepatology Network.
  • He had served on the editorial board of numerous journals including Hepatology, Liver Transplant, JCEH and Gastrointestinal Endoscopy.
  • Dr. Thuluvath is a frequent speaker and lecturer at national and international meetings on issues in liver and biliary diseases and has addressed medical groups in Asia, Europe, North and South America.

Endoscopy Devices Market to Reach $43.82 Bn, Globally, by 2027 at 4.1% CAGR: Allied Market Research

Retrieved on: 
星期二, 十一月 17, 2020
Medicine, Academic journals, Diagnostic gastroenterology, Gastrointestinal Endoscopy, Minimally invasive procedure, Endoscopy

According to the report, the global endoscopy devices industry garnered $31.78 billion in 2019, and is projected to generate $43.82 billion by 2027, growing at a CAGR of 4.1% from 2019 to 2027.

Key Points: 
  • According to the report, the global endoscopy devices industry garnered $31.78 billion in 2019, and is projected to generate $43.82 billion by 2027, growing at a CAGR of 4.1% from 2019 to 2027.
  • Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/1483?reqf...
    Rise in prevalence of diseases that need endoscopy devices during treatment, technological advancements, and adoption of minimally invasive surgeries by patients propel the growth of the global endoscopy devices market.
  • On the other hand, supportive FDA approvals and reimbursement regulations in developing countries present new opportunities in the coming years.
  • By application, the gastrointestinal endoscopy segment accounted for the largest market share, holding around one-fourth of the global endoscopy devices market in 2019, and is expected to maintain its leadership status by 2027.

Endoscopy Devices Market to Reach $43.82 Bn, Globally, by 2027 at 4.1% CAGR: Allied Market Research

Retrieved on: 
星期二, 十一月 17, 2020
Medicine, Academic journals, Diagnostic gastroenterology, Gastrointestinal Endoscopy, Minimally invasive procedure, Endoscopy

According to the report, the global endoscopy devices industry garnered $31.78 billion in 2019, and is projected to generate $43.82 billion by 2027, growing at a CAGR of 4.1% from 2019 to 2027.

Key Points: 
  • According to the report, the global endoscopy devices industry garnered $31.78 billion in 2019, and is projected to generate $43.82 billion by 2027, growing at a CAGR of 4.1% from 2019 to 2027.
  • Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/1483?reqf...
    Rise in prevalence of diseases that need endoscopy devices during treatment, technological advancements, and adoption of minimally invasive surgeries by patients propel the growth of the global endoscopy devices market.
  • On the other hand, supportive FDA approvals and reimbursement regulations in developing countries present new opportunities in the coming years.
  • By application, the gastrointestinal endoscopy segment accounted for the largest market share, holding around one-fourth of the global endoscopy devices market in 2019, and is expected to maintain its leadership status by 2027.